Getty Realty Corp
NYSE:GTY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Getty Realty Corp
NYSE:GTY
|
US |
|
A
|
Arecor Therapeutics PLC
F:6UI
|
UK |
Intrinsic Value
The intrinsic value of Getty Realty Corp (GTY) under the Base Case is 30.06 USD per share.
Compared with the current market price of 27.93 USD, the stock appears
Undervalued by 7% .
The intrinsic value is calculated using the DCF method. The model mostly extends the recent record: revenue grows about 9% a year over the next five years, against 9% over the last five, and operating margin stays near last year's 55%. If revenue grew at its five-year pace of 9%, the estimate would be about $33.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
Revenue & Expenses Breakdown
Getty Realty Corp
Earnings Waterfall
Getty Realty Corp
The intrinsic value for Getty Realty Corp (GTY) under the Base Case is 30.06 USD.
Compared with the current market price of 27.93 USD, the stock appears Undervalued by 7% .